Understanding the link between birth defects and preterm birth

  • Research institute:

    UCL Great Ormond Street Institute of Child Health,
    London

  • Project dates:

    Grant Awarded: 7 Jan 2025

  • Funding awarded:

    Grant Amount (Borne’s share): £119,994
    Total Award: £239,987

Babies born with birth defects are also more likely to be born preterm – but we don’t know why this is. Prof Andrew Copp and his team hope to provide some answers in this project funded by Borne. This could eventually lead to new ways to predict and prevent preterm birth in babies with birth defects.

The challenge

About 3% of all babies are born with birth defects, such as spina bifida or limb malformations. These can severely affect a child’s health throughout life. It’s also known that babies with birth defects are more likely to be born preterm – but we don’t understand why this happens.

Pregnant women are advised to take folic acid during pregnancy to reduce the chances of birth defects such as spina bifida. Research has also found that folic acid can reduce chances of preterm birth. But we don’t know if that is because of its effects of reducing birth defects, or for another reason.

We need to better understand the link between birth defects and preterm birth, so that we can prevent all babies from being born too soon.

The project

In this project, Prof Andrew Copp and his colleagues are studying the link between birth defects, folic acid, and preterm birth. They are using a special breed of mice that are prone to giving birth to pups with birth defects. Prof Copp has shown in previous research that, like humans, these mice may be more likely to give birth prematurely.

In blood samples taken from the pregnant mice, Prof Copp is trying to find molecules that could be measured to help assess risk of preterm birth. They are also testing whether changing folic acid consumption affects the risk of preterm birth in these mice.

What difference will this project make?

Prof Andrew Copp’s research is providing clues about why birth defects increase the chances of preterm birth. This could shed light on the causes of preterm birth in babies without birth defects too. The research could also find out whether folic acid could help to reduce preterm birth generally.

This research could one day help predict and prevent preterm birth in babies with birth defects, and help improve their chances of a healthy life.

“

Determining which factors lead to prematurity when a fetus has a birth defect might provide insight into the causes of premature birth more generally. For example, molecules that we discover to differ in this study can serve as ‘biomarkers’ to indicate when a human pregnancy is at special risk of preterm birth. Our work can also show whether improving folate nutrition is important in helping to reduce prematurity.

”
image
Prof Andrew Copp

This project is jointly funded by Borne and Action Medical Research

Discover other projects

Lunenfeld-Tanenbaum Research Institute, Toronto, Canada

Testing the long-term health impact of a new drug to prevent preterm birth

Prof Stephen Lye and colleagues have identified a drug which can prevent preterm birth in animal studies. In this project, the team are investigating whether the drug improves the long-term health of newborns. The evidence generated promises to enable the team to test the drug in human clinical trials. If successful, this may one day provide a new option to prevent some babies from being born too soon.omega-3 fatty acids in the blood. The evidence generated could change global food and health policy, preventing preterm births and improving the health of mothers and babies worldwide.

Chelsea & Westminster Hospital, London

The FAB study – testing an omega-3 oil supplement to prevent preterm birth

Previous research has suggested that omega-3 fatty acids may prevent preterm birth, but clinical trials of supplements have had mixed results. The FAB study is testing the benefits of a particular supplement in a group of women in India with low levels of omega-3 fatty acids in the blood. The evidence generated could change global food and health policy, preventing preterm births and improving the health of mothers and babies worldwide.

Imperial College London

Investigating how immune cells help the placenta to implant correctly

Dr Viki Male and her team have found that immune cells called uNK1 cells may play a key role in helping the placenta implant into the womb correctly. In this project, Dr Male is studying tiny protein-filled packages inside uNK1 cells, to understand exactly how they might support placental implantation.